Ga-labeling of RGD peptides and biodistribution

International Journal of Clinical and Experimental Medicine

Volumn 5, Issue 2, 2012, Pages 165-172

  Blom, Elisabeth ^a   Velikyan, Irina ^b,c   Estrada, Sergio ^b   Hall, Håkan ^b   Muhammad, Taj ^b   Ding, Chenmin ^b   Nair, Manoj ^b   Långström, Bengt ^a,d,e  

^a Department of Biochemistry and Organic Chemistry ^*  (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Ga; Biodistribution; RGD

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; CHELATING AGENT; GALLIUM 68; TETRAXETAN;

ANALYTIC METHOD; ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; MALE; MICROWAVE RADIATION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT;

EID: 84859976754     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Folkman J. Tumor angiogenesis: therapeutic implications. New Engl J Med 1971; 285: 1182-1186.
2. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002; 29: 15-18.
3. Janssen ML, Oyen WJ, Dijkgraaf I, Massuger LF, Frielink C, Edwards DS, Rajopadhye M, Boonstra H, Corstens FH, Boerman OC. Tumor targeting with radiolabeled αvβ3 integrin binding peptides in a nude mouse model. Cancer Res 2002; 62: 6146-6151.
4. Kok RJ, Schraa AJ, Bos EJ, Moorlag HE, Asgeirs-dottir SA, Everts M, Meijer DKF, Molema G. Preparation and Functional Evaluation of RGD-Modified Proteins as αvβ3 Integrin Directed Therapeutics. Bioconj Chem 2002; 13: 128-135.
5. Garanger E, Boturyn D, Jin Z, Dumy P, Favrot M-C, Coll J-L. New Multifunctional Molecular Conjugate Vector for Targeting, Imaging, and Therapy of Tumors. Mol Ther 2005; 12: 1168-1175.
6. Dijkgraaf I, Yim C-B, Franssen GM, Schuit RC, Luurtsema G, Liu S, Oyen WJG, Boerman OC. PET imaging of αvβ3 integrin expression in tumours with 68Ga-labelled mono-, di- and tetrameric RGD peptides. Eur J Nucl Med Mol Imaging 2011; 38: 128-137.
7. Lee HY, Kang KW, Kim T-Y, Lee Y-S, Jeong JM, Han S-W, Paeng JC, Chung J-K, Lee MC, Lee DS. Angiogenesis imaging using 68Ga-RGD PET: preliminary report from Seoul National University Hospital. Curr Med Imaging Rev 2010; 6: 56-59.
8. Liu Z, Niu G, Shi J, Liu S, Wang F, Liu S, Chen X. 68Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor in-tegrin αvβ3 PET imaging. Eur J Nucl Med Mol imaging 2009; 36: 947-957.
9. Li Z-B, Chen K, Chen X. 68Ga-labeled multimeric RGD peptides for microPET imaging of integrin αvβ3 expression. Eur J Nucl Med Mol Imaging 2008; 35: 1100-1108.
10. Decristoforo C, Hernandez GI, Carlsen J, Rup-prich M, Huisman M, Virgolini I, Wester H-J, Haubner R. 68Ga- and 111In-labelled DOTA-RGD peptides for imaging of alphavbeta3 integrin expression. Eur J Nucl Med Mol Imaging 2008; 35: 1507-1515.
11. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin αvβ3 for angiogenesis. Sci ence 1994; 264: 569-571.
12. Horton MA. The αvβ3 integrin vitronectin receptor. Int J Biochem Cell Biol 1997; 29: 721-725.
13. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987; 238: 491-497.
14. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11-25.
15. Ruoslahti E. The RGD story: a personal account. Matrix Biology 2003; 22: 459-465.
16. Davis FF, Abuchowski A, Van Es T, Palczuk NC, Chen R, Savoca K, Wieder K. Enzyme-polyethylene glycol adducts: modified enzymes with unique properties. Enzyme Engl 1978; 4: 169-173.
17. Chen X, Park R, Shahinian AH, Bading JR, Conti PS. Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PE-Gylation. Nucl Med Biol 2004; 31: 11-19.
18. Roberts MJ, Bentley MD, Harris JM. Chemistry for peptide and protein PEGylation. Adv Drug Delivery Rev 2002; 54: 459-476.
19. Janssen ML, Oyen WJ, Dijkgraaf I, Massuger LF, Frielink C, Edwards DS, Rajopadhye M, Boonstra H, Corstens FH, Boerman OC. Tumor targeting with radiolabeled αvβ3 integrin binding peptides in a nude mouse model. Cancer Res 2002; 62: 6146-6151.
20. Chen X, Liu S, Hou Y, Tohme M, Park R, Bading JR, Conti PS. MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides. Mol Imaging Biol 2004; 6: 350-359.
21. Dubey PK, Mishra V, Jain S, Mahor S, Vyas SP. Liposomes modified with cyclic RGD peptide for tumor targeting. J Drug Target 2004; 12: 257-264
22. Schiffelers RM, Koning GA, ten Hagen TLM, Fens MHAM, Schraa AJ, Janssen APCA, Kok RJ, Molema G, Storm G. Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. J Control Release 2003; 91: 115-122.
23. Indrevoll B, Mørk Kindberg G, Solbakken M, Bjur-gert E, Johansen JH, Karlsen H, Mendizabal M, Cuthbertson A. NC-100717: A versatile RGD peptide scaffold for angiogenesis imaging. Bio-org Med Chem Lett 2006; 16: 6190-6193.
24. Broan CJ, Cox JPL, Craig AS, Kataky R, Parker D, Harrison A, Randall AM, Ferguson G. Structure and solution stability of indium and gallium complexes of 1,4,7-triazacyclononanetriacetate and of yttrium complexes of 1,4,7,10-tetraazacyclododecanetetraacetate and related ligands: kinetically stable complexes for use in imaging and radioimmunotherapy. X-ray molecular structure of the indium and gallium complexes of 1,4,7-triazacyclononane-1,4,7-triacetic acid. J Chem Soc Perkin Trans 1991; 21: 87-99.
25. Craig AS, Parker D, Adams H, Bailey NA. Stability, gallium-71 NMR and crystal structure of a neutral gallium(III) complex of 1,4,7-triazacyclononanetriacetate: a potential radio-pharmaceutical? J Chem Soc Chem Commun 1989; 23: 1793-1794.
26. Heppeler A, Froidevaux S, Mäcke HR, Jermann E, Béhé M, Powell P, Hennig M. Radiometal-labelled macrocyclic chelator-derivatized soma-tostatin analogue with superb tumour-targeting properties and potential for receptor-mediated internal radiotherapy. Chem Eur J 1999; 5: 1974-1981.